FDA Action on Loperamide Misuse; Plus Phase 1 Trials for BAT2506 Biosimilar Begin Michele B. Kaufman, PharmD, BCGP | November 20, 2019The FDA has limited the package size of some over-the-counter loperamide products to prevent its potential misuse and abuse…
